Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Hepatitis B Seroprevalence in Risk Groups | Synapse
March 3, 2026
Open Access
Hepatitis B Seroprevalence in Risk Groups
AB
Ali İhsan Bozkurt
Dicle University
MK
Mehmet KARATAS
İK
İlkay KARAOĞLU
Puntos clave
Hepatitis B seroprevalence was notably high in identified risk groups, indicating severe public health concerns.
The analysis found a seroprevalence rate of 10% among injection drug users and 5% among men who have sex with men.
Observational analysis focused on various risk groups and their exposure to hepatitis B viral infection.
This highlights the urgent need for better screening and vaccination strategies in vulnerable populations.
Leer artículo completo
externamente
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Ver artículo completo
Cite This Study
Copy
Bozkurt et al. (Wed,) studied this question.
synapsesocial.com/papers/69a760edc6e9836116a2e39c
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Ver artículo completo